|
RFFL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.945800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.818600E-01 |
| Normal-vs-Stage2 |
3.727000E-01 |
| Normal-vs-Stage3 |
7.342200E-02 |
| Normal-vs-Stage4 |
6.595800E-02 |
| Stage1-vs-Stage2 |
1.606020E-01 |
| Stage1-vs-Stage3 |
3.201800E-02 |
| Stage1-vs-Stage4 |
4.208100E-02 |
| Stage2-vs-Stage3 |
3.020000E-01 |
| Stage2-vs-Stage4 |
1.263570E-01 |
| Stage3-vs-Stage4 |
6.185000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.846200E-01 |
| Normal-vs-AfricanAmerican |
9.378100E-02 |
| Normal-vs-Asian |
3.896600E-01 |
| Caucasian-vs-AfricanAmerican |
4.037900E-04 |
| Caucasian-vs-Asian |
4.897200E-01 |
| AfricanAmerican-vs-Asian |
2.676600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.668400E-01 |
| Normal-vs-Female |
7.880000E-02 |
| Male-vs-Female |
4.018000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.327600E-01 |
| Normal-vs-Extreme_Weight |
3.022000E-01 |
| Normal-vs-Obese |
2.236800E-01 |
| Normal-vs-Extreme_Obese |
5.316000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.387370E-01 |
| Normal_Weight-vs-Obese |
8.457600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.647400E-01 |
| Extreme_Weight-vs-Obese |
2.742300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.654600E-01 |
| Obese-vs-Extreme_Obese |
3.187600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.883700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.559600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.143600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.133600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.550960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.317900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.107800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.438590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.082400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.348600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.911600E-01 |
| Normal-VS-Type2 PRCC |
1.313600E-01 |
| Normal-VS-KIRP CIMP |
2.12249999999026E-05 |
| Normal-VS-Unclassified PRCC |
6.394000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.330200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.8306000005317E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
2.480600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.492400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.078800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.238500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.243000E-01 |
| Normal-vs-N1 |
2.656000E-03 |
| Normal-vs-N2 |
3.128500E-02 |
| N0-vs-N1 |
3.981200E-03 |
| N0-vs-N2 |
8.532500E-02 |
| N1-vs-N2 |
6.365600E-01 |
|
|
